3 R study: Renal outcome in renal ischemia: Revascularisation or medical treatment

Journal of Nephrology

Volumn 13, Issue 2, 2000, Pages 106-109

  Zuccalà, Alessandro ^a,b   Zucchelli, Pietro ^a   Campieri, Claudio ^c   Esposti, Ezio Degli ^d   Losito, Attilio ^e   Timio, Mario ^e   Boero, Roberto ^f  

^a Ischemic Nephropathy   (Italy)

^b Divisione di Nefrologia e Dialisi   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d Renovascular Hypertension Stud Grp   (Italy)

^e Italian Society of Nephrology   (Italy)

^f Ischemic Nephropathy   (Italy)

Author keywords

Ischemic nephropathy; Palmaz stent; Percutaneous renal angioplasties; Renovascular hypertension

Indexed keywords

ACETYLSALICYLIC ACID; TICLOPIDINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY STENOSIS; KIDNEY ISCHEMIA; MAJOR CLINICAL STUDY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RANDOMIZED CONTROLLED TRIAL; RENOVASCULAR HYPERTENSION; REVASCULARIZATION; STENT; VASCULAR SURGERY;

FOLLOW-UP STUDIES; HUMANS; ISCHEMIA; KIDNEY; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RENAL ARTERY OBSTRUCTION;

EID: 0034014957     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hansen KJ. Prevalence of ischemic nephropathy in the atherosclerotic population. Am J Kidney Dis 1994; 24: 615-21.
2. Zucchelli P and Zuccalà A. Ischemic nephropathy in the elderly. Contrib Nephrol 1993; 105: 13-22.
3. Jacobson HR. Ischemic renal disease: an overlooked clinical entity? Kidney Int 1988; 34: 729-43.
4. Krijen P, van Jaarsveld BC, Steyeberg EW, Man in't Veld AJ, Schalekamp MA, Habbena JD. A clinical prediction rule for renal artery stenosis. Ann Intern Med 1998; 129: 705-11.
5. Greco B, Breyer JA. The natural history of renal artery stenosis: Who should be evaluated for suspected ischemic nephropathy? Sem Nephrol 1996; 2-11.
6. Harden PN, Mac Leod MJ, Rodger RSC et al. Effect of renal artery stenting on progression of renovascular renal failure. Lancet 1997; 349: 1133-6.
7. Van Jaarsveld B, Krijnen P, Barktelink A, Dees A, Man in't Veld AJ, Schlekamp M. The Dutch Renal Artery Stenosis Intervention Cooperative (DRASTIC) Study: rationale, design and inclusion data. J Hypertens 1998; 16 (suppl): S21-7.
8. Plouin PF, Chatellier G, Darne B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998; 31: 823-9.
9. Van de Ven PJ, Kaatee R, Beutler JJ, Beek FJ, Woittiez AJ, Buskens E, Koomans HA, Mali WP. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 1999; 353: 282-6.
10. Dean RH, Tribble RW, Hansen KJ, O'Neil EA, Craven TE, Redding JF. Evolution of renal insufficiency in ischemic nephropathy. Ann Surg 1991; 213: 446-56.
11. Brown BG, Zhao XQ, Sacco DE, Albers JJ. Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary artery disease. Circulation 1993; 87: 1781-91.
12. Kane JP, Malley MJ, ports TA, Philips NR, Diehl JC, Havel RJ. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 1990; 264: 3007-12.
13. Furberg CD, Adams HP, Applegate WB et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) research group. Circulation 1994; 90: 1679-87.
14. Basta LL, Williams C, Kloskos JM, Spector AA. Regression of atherosclerotic stenosing lesions of the renal arteries and spontaneous cure of systemic hypertension through control of hyperlipidemia. Am J Med 1976; 61: 420-6.